Identifying the Main Functional Pathways Associated with Cognitive Resilience to Alzheimer’s Disease

• Published in: International journal of molecular sciences Vol. 22; no. 17; p. 9120
• Main Authors: Pérez-González, Marta, Badesso, Sara, Lorenzo, Elena, Guruceaga, Elizabeth, Pérez-Mediavilla, Alberto, García-Osta, Ana, Cuadrado-Tejedor, Mar
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 01-09-2021; MDPI
• Subjects: Alzheimer's disease; Amyloid; CD4 antigen; CD4+ cells; Cognitive ability; cognitive resilience; Dementia; Dementia disorders; Dopamine; Gene expression; Immune system; Inflammation; Leukocytes (mononuclear); Memory; Neurotransmission; Older people; Ontology; Peripheral blood mononuclear cells; Prefrontal cortex; Resilience; Temporal cortex; Transgenic mice
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms22179120

Understanding the mechanisms involved in cognitive resilience in Alzheimer’s disease (AD) represents a promising strategy to identify novel treatments for dementia in AD. Previous findings from our group revealed that the study of aged-Tg2576 cognitive resilient individuals is a suitable tool for this purpose. In the present study, we performed a transcriptomic analysis using the prefrontal cortex of demented and resilient Tg2576 transgenic AD mice. We have been able to hypothesize that pathways involved in inflammation, amyloid degradation, memory function, and neurotransmission may be playing a role on cognitive resilience in AD. Intriguingly, the results obtained in this study are suggestive of a reduction of the influx of peripheral immune cells into the brain on cognitive resilient subjects. Indeed, CD4 mRNA expression is significantly reduced on Tg2576 mice with cognitive resilience. For further validation of this result, we analyzed CD4 expression in human AD samples, including temporal cortex and peripheral blood mononuclear cells (PBMC). Interestingly, we have found a negative correlation between CD4 mRNA levels in the periphery and the score in the Mini-Mental State Exam of AD patients. These findings highlight the importance of understanding the role of the immune system on the development of neurodegenerative diseases and points out to the infiltration of CD4+ cells in the brain as a key player of cognitive dysfunction in AD.